LCLAT1 and type 2 diabetes mellitus: Lastly, ALCAT1 is an acyl-CoA dependent lysocardiolipin acyltransferase that catalyzes the remodeling of aberrant cardiolipin in common metabolic diseases including obesity and type 2 diabetes, and whose expression is upregulated in liver of mouse models of obesity46.